244 related articles for article (PubMed ID: 22453059)
1. Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency.
Rahimi-Ardabili H; Pourghassem Gargari B; Farzadi L
J Endocrinol Invest; 2013 Jan; 36(1):28-32. PubMed ID: 22453059
[TBL] [Abstract][Full Text] [Related]
2. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
[TBL] [Abstract][Full Text] [Related]
3. The effects of vitamin D and evening primrose oil co-supplementation on lipid profiles and biomarkers of oxidative stress in vitamin D-deficient women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
Nasri K; Akrami S; Rahimi M; Taghizadeh M; Behfar M; Mazandaranian MR; Kheiry A; Memarzadeh MR; Asemi Z
Endocr Res; 2018 Feb; 43(1):1-10. PubMed ID: 28742409
[TBL] [Abstract][Full Text] [Related]
4. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
Wang L; Lv S; Li F; Yu X; Bai E; Yang X
Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
[No Abstract] [Full Text] [Related]
6. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization.
Dastorani M; Aghadavod E; Mirhosseini N; Foroozanfard F; Zadeh Modarres S; Amiri Siavashani M; Asemi Z
Reprod Biol Endocrinol; 2018 Oct; 16(1):94. PubMed ID: 30286768
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.
Ardabili HR; Gargari BP; Farzadi L
Nutr Res; 2012 Mar; 32(3):195-201. PubMed ID: 22464806
[TBL] [Abstract][Full Text] [Related]
8. The effect of concentrated pomegranate juice consumption on risk factors of cardiovascular diseases in women with polycystic ovary syndrome: A randomized controlled trial.
Abedini M; Ghasemi-Tehrani H; Tarrahi MJ; Amani R
Phytother Res; 2021 Jan; 35(1):442-451. PubMed ID: 32767710
[TBL] [Abstract][Full Text] [Related]
9. Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.
Foroozanfard F; Jamilian M; Bahmani F; Talaee R; Talaee N; Hashemi T; Nasri K; Asemi Z; Esmaillzadeh A
Clin Endocrinol (Oxf); 2015 Dec; 83(6):888-94. PubMed ID: 26119844
[TBL] [Abstract][Full Text] [Related]
10. Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review.
Menichini D; Facchinetti F
Gynecol Endocrinol; 2020 Jan; 36(1):1-5. PubMed ID: 31187648
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D deficiency effects on cardiovascular parameters in women with polycystic ovary syndrome: A retrospective, cross-sectional study.
Butler AE; Dargham SR; Abouseif A; El Shewehy A; Atkin SL
J Steroid Biochem Mol Biol; 2021 Jul; 211():105892. PubMed ID: 33785436
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D Supplementation Decreases TGF-β1 Bioavailability in PCOS: A Randomized Placebo-Controlled Trial.
Irani M; Seifer DB; Grazi RV; Julka N; Bhatt D; Kalgi B; Irani S; Tal O; Lambert-Messerlian G; Tal R
J Clin Endocrinol Metab; 2015 Nov; 100(11):4307-14. PubMed ID: 26485217
[TBL] [Abstract][Full Text] [Related]
13. A Cross-Sectional Exploratory Study of Cardiovascular Risk Biomarkers in Non-Obese Women with and without Polycystic Ovary Syndrome: Association with Vitamin D.
Nandakumar M; Das P; Sathyapalan T; Butler AE; Atkin SL
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928037
[TBL] [Abstract][Full Text] [Related]
14. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
15. Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
Jamilian M; Foroozanfard F; Kavossian E; Aghadavod E; Shafabakhsh R; Hoseini A; Asemi Z
Clin Nutr ESPEN; 2020 Apr; 36():128-133. PubMed ID: 32220355
[TBL] [Abstract][Full Text] [Related]
16. The short-term effects of vitamin D repletion on cholesterol: a randomized, placebo-controlled trial.
Ponda MP; Dowd K; Finkielstein D; Holt PR; Breslow JL
Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2510-5. PubMed ID: 22947589
[TBL] [Abstract][Full Text] [Related]
17. Assessing cardiovascular risk in Mediterranean women with polycystic ovary syndrome.
Rizzo M; Longo RA; Guastella E; Rini GB; Carmina E
J Endocrinol Invest; 2011 Jun; 34(6):422-6. PubMed ID: 20959718
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Calcium, Vitamins D and K co-Supplementation on Markers of Insulin Metabolism and Lipid Profiles in Vitamin D-Deficient Women with Polycystic Ovary Syndrome.
Karamali M; Ashrafi M; Razavi M; Jamilian M; Akbari M; Asemi Z
Exp Clin Endocrinol Diabetes; 2017 May; 125(5):316-321. PubMed ID: 28407660
[TBL] [Abstract][Full Text] [Related]
19. The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial.
Seyyed Abootorabi M; Ayremlou P; Behroozi-Lak T; Nourisaeidlou S
Gynecol Endocrinol; 2018 Jun; 34(6):489-494. PubMed ID: 29271278
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance.
Joham AE; Teede HJ; Cassar S; Stepto NK; Strauss BJ; Harrison CL; Boyle J; de Courten B
Mol Nutr Food Res; 2016 Jan; 60(1):110-8. PubMed ID: 26255991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
